Skip to main content

Significance of α1-6 Fucosylation in Hepatocellular Carcinoma

  • Conference paper
Liver Cirrhosis

Summary

α1-6 Fucosyltransferase (α1-6FucT) catalyzes the transfer of fucose from GDP-Fuc to N-linked type complex glycoproteins. Recently, serum α1-6 fucosylated α-fetoprotein (AFP) has been employed for a differential diagnosis of hepatocellular carcinoma (HCC) from liver cirrhosis. To determine the molecular basis of the fucosylated AFP in the serum of patients with HCC, we have succeeded in the purification and cDNA cloning of α1-6FucT from porcine brain and a gastric cancer cell line, respectively. Their homology is 92.2% at the nucleotide level and 95.7% at the amino acid level. No putative N-glycosylation sites were found in the predicted amino acid sequence. α1-6FucT was widely expressed in various rat tissues except normal liver. Expression of α1-6FucT in the liver was enhanced during hepatocarcinogenesis of LEC rats, which develop hereditary hepatitis and hepatomas. In human liver diseases, α1-6FucT was expressed in both HCCs and their surrounding tissues with chronic liver disease, but not in normal liver. Although serum AFP has been employed for an early diagnosis of patients with HCC, the mechanisms by which α1-6 fucosylation of AFP occurs in HCC seem to be not solely due to the up-regulation of α1-6FucT. Interestingly, when the α1-6FucT gene was transfected into Hep3B, a human hepatoma cell line, tumor formation in the liver of nude mice after splenic injection was dramatically suppressed. The mechanisms of the suppression were due to decreases in cell adhesion through aberrant glycosylation of α5β1 integrin. In this review, we focus on the biological significance of α1-6 fucosylation in HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hakomori S-I (1989) Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 52: 257–331

    Article  PubMed  CAS  Google Scholar 

  2. Wilson JR, Williams D, Schachter H (1976) The control of glycoprotein synthesis: N-acetylglucosamine linkage to a mannose residue as a signal of L-fucose to the asparagine-linked N-acetylglucosamine residue of glycopeptide from al-acid glycoprotein. Biochem Biophys Res Commun 72: 909–916

    Article  PubMed  CAS  Google Scholar 

  3. Longmore GD, Schachter H (1982) Product-identification and substrate specificity studies of the GDP-fucose:2-acetamide-2-deoxy-β-D-glucoside (Fuc-linked GlcNAc)6a-L-fucosyltransferase in a Golgi-rich fraction from porcine liver. Carbohydr Res 100: 365–392

    Article  PubMed  CAS  Google Scholar 

  4. Shimizu H, Ochiai K, Ikenaka K, et al. (1993) Structures of N-linked sugar chains expressed mainly in mouse brain. J Biochem 114: 334–338

    PubMed  CAS  Google Scholar 

  5. Yamashita K, Liang C-J, Funakoshi S, et al. (1981) Structural studies of asparagine-linked sugar chains of human ceruloplasmin. J Biol Chem 256: 1283–1289

    PubMed  CAS  Google Scholar 

  6. Yamashita K, Ideo H, Ohkura T, et al. (1993) Sugar chains of serum transferrin from patients with carbohydrate deficient glycoprotein syndrome. J Biol Chem 268: 5783–5789

    PubMed  CAS  Google Scholar 

  7. Santer UV, Glick MC (1979) Partial structure of a membrane glycopeptide from virus-transformed hamster cells. Biochemistry 18: 2533–2540

    Article  PubMed  CAS  Google Scholar 

  8. Brzborowicz J, Mackiewicz A, Brzborowicz D (1981) Microheterogeneity of afetoprotein in patient serum as demonstrated by lectin affino-electrophoresis. Scand J Immunol 14: 15–20

    Article  Google Scholar 

  9. Taketa K, Ichikawa E, Umetsu K, et al. (1986) Allomyrina dichotoma lectin-nonreactive a-fetoprotein in hepatocellular carcinoma and other tumors: comparison with Ricinus communis agglutinin-I. Cancer Lett 31: 325–331

    Google Scholar 

  10. Champion B, Leger D, Wieruszeski J-M, et al. (1989) Presence of fucosylated triantennary, tetraantennary and pentaantenary glycans in transferrin synthesized by the human hepatocarcinoma cell line HepG2. Eur J Biochem 184: 405–413

    Article  Google Scholar 

  11. Koscielak J, Pacuszka T, Kubin J, et al. (1987) Serum α-6-L-fucosyltransferase is released from platelets during clotting of blood. Glycoconjugate J 4: 43–49

    Article  CAS  Google Scholar 

  12. Koscielak J, Antoniewicz-Papis J, Zdebska E, et al. (1995) Activity of platelet a-6fucosyltransferase is inversely related to blood platelet concentration. Acta Biochim Polon 42: 35–39

    PubMed  CAS  Google Scholar 

  13. Tatsumura T, Sato H, Mori A, et al. (1997) Clinical significance of fucose level in glycoprotein fraction of serum in patients with malignant tumors. Cancer Res 37: 4101–4103

    Google Scholar 

  14. Uozumi N, Yanagidani S, Miyoshi E, et al. (1996) Purification and cDNA cloning of porcine brain GDP-L-Fuc:N-acetyl-13-D-glucosaminide:a1–6 fucosyltransferase. J Biol Chem 271: 27810–27817

    Article  PubMed  CAS  Google Scholar 

  15. Yanagidani S, Uozumi N, Ihara Y, Miyoshi E, et al. (1997) Purification and cDNA cloning of GDP-L-Fuc:N-acetylglucosaminide:al-6 fucosyltransferase (a1–6FucT) from human stomach carcinoma MKN45 cells. J Biochem 121: 626–632

    Article  PubMed  CAS  Google Scholar 

  16. Wang YM, Hare TR, Won B, et al. (1990) Additional fucosyl residues on membrane glycoproteins but not on secreted glycoprotein from cystic fibrosis fibroblasts. Clin Chim Acta 188: 193–210

    Article  PubMed  CAS  Google Scholar 

  17. Voynow JA, Kaiser RS, Scanlin TF, et al. (1991) Purification and characterization of GDP-L-Fuc:N-acetyl-(3-D-glucosaminide al-6 fucosyltransferase from cultured human skin fibroblasts. J Biol Chem 266: 21572–21577

    PubMed  CAS  Google Scholar 

  18. Breton C, Oriol R, Imberty A (1998) Conserved structural features in eukaryotic and prokaryotic fucosyltransferases. Glycobiology 8: 87–94

    Article  PubMed  CAS  Google Scholar 

  19. Miyoshi E, Uozumi N, Noda K, et al. (1997) Expression of al-6 fucosyltransferase in rat tissues and human cancer cell lines. Int J Cancer 72: 1117–1121

    Article  PubMed  CAS  Google Scholar 

  20. Kaminska J, Glick MC, Koscielak J (1998) Purification and characterization of GDPL-Fuc:N-acetyl (3-D-glucosaminide a1–6 fucosyltransferase from human blood platelets. Glycoconjugate J 15: 783–788

    Article  CAS  Google Scholar 

  21. Bergstrand CG, Czar B (1956) Demonstration of new protein fraction in serum from the human fetus. Scand J Clin Lab Invest 8: 174

    Article  PubMed  CAS  Google Scholar 

  22. Halbrecht I, Klibanski C (1956) Identification of a new normal embryonic hemoglobin. Nature 178: 794–795

    Article  PubMed  CAS  Google Scholar 

  23. Abelev GI, Perova SD, Khramkova NI, et al. (1963) Production of embryonal a-globulin by transplantable mouse hepatomas. Transplant Bull 1: 174–180

    Article  CAS  Google Scholar 

  24. Tatarinov YS (1963) The discovery of fetal globulin in patients with primary cancer of the liver. First International Biochemistry Congress of the USSR. Moscow: Academy of Sciences USSR, 274

    Google Scholar 

  25. Tatarinov YS (1964) Presence of embryo specific a-globulin in the serum of patients with primary hepatocellular carcinoma. Vopr Med Khim 10: 90–91

    PubMed  CAS  Google Scholar 

  26. Alpert ME, Uriel J, de Nechaud B (1968) al Fetogloblin in the diagnosis of human hepatoma. N Engl J Med 278: 984–986

    Google Scholar 

  27. Di Bisceglie AM, Hoofnagle JH (1989) Elevations in serum a-fetoprotein levels in patients with chronic hepatitis B. Cancer 64: 2117–2120

    Article  PubMed  Google Scholar 

  28. Sawadaishi K, Morinaga T, Tamaoki T (1988) Interaction of a hepatoma-specific nuclear factor with transcription-regulatory sequences of human a-fetoprotein and albumin genes. Mol Cell Biol 8: 5179–5187

    PubMed  CAS  Google Scholar 

  29. Nakabayashi H, Watanabe K, Saito A, et al. (1989) Transcriptional regulation of afetoprotein expression by dexamethasone in human hepatoma cells. J Biol Chem 264: 266–271

    PubMed  CAS  Google Scholar 

  30. Morinaga T, Sakai M, Wegmann TG, et al. (1983) Primary structures of human afetoprotein and its mRNA. Proc Natl Acad Sci USA 80: 4604–4608

    Article  PubMed  CAS  Google Scholar 

  31. Gibbs PEM, Zielinski R, Boyd C, et al. (1987) Structure, polymorphism and novel repeated DNA elements revealed by a complete structure of the human a-fetoprotein gene. Biochemistry 26: 1332–1343

    Article  PubMed  CAS  Google Scholar 

  32. Breborowicz J, Mackiewicz A, Breborowicz D (1981) Microheterogeneity of afetoprotein in patient serum as demonstrated by lectin affino-electrophoresis. Scand J Immunol 14: 15–20

    Article  PubMed  CAS  Google Scholar 

  33. Miyazaki J, Endo Y, Oda T (1981) Lectin affinities of a-fetoprotein in liver cirrhosis, hepatocellular carcinoma and metastatic liver tumor. Acta Hepatol Jpn 22: 1559–1568

    Article  CAS  Google Scholar 

  34. Kornfeld K, Reitman ML, Kornfeld R (1981) The carbohydrate-binding specificity of pea and lentil lectins. J Biol Chem 256: 6633–6640

    PubMed  CAS  Google Scholar 

  35. Taketa K, Ichikawa E, Taga H, et al. (1985) Antibody-affinity blotting, a sensitive technique for the detection of a-fetoprotein separated by lectin affinity electrophoresis in agarose gels. Electrophoresis 6: 492–497

    Article  CAS  Google Scholar 

  36. Aoyagi Y, Suzuki Y, Igarashi K, et al. (1991) The usefulness of simultaneous determinations of glucosaminylation and fucosylation induces of a-fetoprotein in the differential diagnosis of neoplastic diseases of the liver. Cancer 67: 2390–2394

    Article  PubMed  CAS  Google Scholar 

  37. Taketa K, Sekiya C, Namiki M, et al. (1990) Lectin-reactive profiles of a-fetoprotein characterizing hepatocellular carcinoma and related conditions. Gastroenterology 99: 508–518

    PubMed  CAS  Google Scholar 

  38. Taketa K, Endo Y, Sekiya C, et al. (1993) A collaborative study for the evaluation of lectin-reactive a-fetoprotein in early detection of hepatocellular carcinoma. Cancer Res 53: 5419–5423

    PubMed  CAS  Google Scholar 

  39. Sato Y, Nakata K, Kato Y, et al. (1993) Early recognition of hepatocellular carcinoma based on altered profiles of a-fetoprotein. N Engl J Med 328: 1802–1806

    Article  PubMed  CAS  Google Scholar 

  40. Shiraki K, Takase K, Tameda Y, et al. (1995) A clinical study of lectin-reactive afetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients. Hepatology 22: 802–807

    Article  PubMed  CAS  Google Scholar 

  41. Yamashita F, Tanaka M, Satomura S, et al. (1996) Prognostic significance of Lens Culinaris Agglutinin-reactive a-fetoprotein in small hepatocellular carcinomas. Gastroenterology 111: 996–1001

    Article  PubMed  CAS  Google Scholar 

  42. Aoyagi Y, Isokawa O, Suda T, et al. (1998) The fucosylation index of a-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma. Cancer 83: 2076–2082

    Article  PubMed  CAS  Google Scholar 

  43. Miyoshi E, Fujii J, Hayashi N, et al. (1997) LEC rats: an overview of recent findings. J Trace Elem Exp Med 10: 135–145

    Article  Google Scholar 

  44. Noda K, Miyoshi E, Uozumi N, et al. (1998) High expression of al-6 fucosyltransferase during rat hepatocarcinogenesis. Int J Cancer 75: 444–450

    Article  PubMed  CAS  Google Scholar 

  45. Hutchinson WL, Du M-Q, Johnson PJ, et al. (1991) Fucosyltransferases: differential plasma and tissue alterations in hepatocellular carcinoma and cirrhosis. Hepatology 13: 683–688

    Article  PubMed  CAS  Google Scholar 

  46. Noda K, Miyoshi E, Uozumi N (1998) Gene expression of al-6 fucosyltransferase in human hepatoma tissues: a possible implication for increased fucosylation of a feto-protein. Hepatology 28: 944–952

    Article  PubMed  CAS  Google Scholar 

  47. Miyoshi E, Noda K, Ko JH, et al. (1999) Overexpression of a1–6 fucosyltransferase in hepatoma cells suppresses intrahepatic metastasis after splenic injection in athymic mice. Cancer Res 59: 2237–2243

    PubMed  CAS  Google Scholar 

  48. Stubbs HJ, Lih JJ, Gustafson TL, et al. (1996) Influence of core fucosylation on the flexibility of a biantennary N-linked oligosaccharide. Biochemistry 35: 937–947

    Article  PubMed  CAS  Google Scholar 

  49. Kojima N, Yachida Y, Yoshida Y, et al. (1996) Characterization of mouse ST SialI(STX) as a neural cell adhesion molecule-specific polysialic acid synthase. J Biol Chem 271: 19457–19463

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Tokyo

About this paper

Cite this paper

Miyoshi, E., Noda, K., Taniguchi, N., Sasaki, Y., Hayashi, N. (2001). Significance of α1-6 Fucosylation in Hepatocellular Carcinoma. In: Okita, K. (eds) Liver Cirrhosis. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68343-8_12

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-68343-8_12

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-68345-2

  • Online ISBN: 978-4-431-68343-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics